Big news of the month; the arrival of the Alamar ARGO HT NULISA™ system, a major technological advance for the detection of previously inaccessible biomarkers.
This technology enables the simultaneous analysis of up to 250 proteins, including critical biomarkers such as pTau217 and α-Synuclein, NULISA™ opens up new perspectives for research in: Neurology / Inflammation / Oncology / Immunology ..and many others!
Using just 25 to 35 µL of sample, this platform makes it possible to work on complex matrices (serum, plasma, CSF, cell culture supernatant, etc.) while guaranteeing ultra-sensitive analysis.
